SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Cho I.) "

Sökning: WFRF:(Cho I.)

  • Resultat 1-10 av 539
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Aad, G., et al. (författare)
  • 2012
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  • Aad, G., et al. (författare)
  • 2012
  • swepub:Mat__t (refereegranskat)
  •  
3.
  • Aad, G., et al. (författare)
  • 2012
  • swepub:Mat__t (refereegranskat)
  •  
4.
  • 2021
  • swepub:Mat__t
  •  
5.
  •  
6.
  • Niemi, MEK, et al. (författare)
  • 2021
  • swepub:Mat__t
  •  
7.
  •  
8.
  • Lind, Lars, et al. (författare)
  • Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight NCD Risk Factor Collaboration (NCD-RisC)
  • 2021
  • Ingår i: eLife. - : eLife Sciences Publications Ltd. - 2050-084X. ; 10
  • Tidskriftsartikel (refereegranskat)abstract
    • From 1985 to 2016, the prevalence of underweight decreased, and that of obesity and severe obesity increased, in most regions, with significant variation in the magnitude of these changes across regions. We investigated how much change in mean body mass index (BMI) explains changes in the prevalence of underweight, obesity, and severe obesity in different regions using data from 2896 population-based studies with 187 million participants. Changes in the prevalence of underweight and total obesity, and to a lesser extent severe obesity, are largely driven by shifts in the distribution of BMI, with smaller contributions from changes in the shape of the distribution. In East and Southeast Asia and sub-Saharan Africa, the underweight tail of the BMI distribution was left behind as the distribution shifted. There is a need for policies that address all forms of malnutrition by making healthy foods accessible and affordable, while restricting unhealthy foods through fiscal and regulatory restrictions.
  •  
9.
  •  
10.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 539
Typ av publikation
tidskriftsartikel (527)
forskningsöversikt (5)
konferensbidrag (3)
Typ av innehåll
refereegranskat (521)
övrigt vetenskapligt/konstnärligt (16)
Författare/redaktör
Zhou, B. (326)
Zhu, J. (319)
Davies, G (319)
Meyer, J. (318)
Xie, Y. (318)
Fox, H. (317)
visa fler...
Adams, T. (317)
Abbott, B. (316)
Brandt, A. (316)
Brock, R. (316)
Kupco, A. (316)
Pleier, M. -A. (316)
Sawyer, L. (316)
Schwanenberger, C. (316)
Schwienhorst, R. (316)
Severini, H. (316)
Shabalina, E. (316)
Snyder, S. (316)
Stark, J. (316)
Watts, G. (316)
Bernhard, R. (316)
Borissov, G. (315)
Burdin, S. (315)
Cooke, M. (315)
Evans, H. (315)
Hensel, C. (315)
Khanov, A. (315)
Lokajicek, M. (315)
Qian, J. (315)
Strauss, M. (315)
Tsybychev, D. (315)
Buescher, V. (315)
Fiedler, F. (314)
Han, L. (314)
Kehoe, R. (314)
Quadt, A. (314)
Rizatdinova, F. (314)
Zieminska, D. (314)
Grivaz, J. -F. (314)
Adams, M. (314)
Hohlfeld, M. (313)
De La Cruz-Burelo, E ... (313)
Alton, A. (313)
Askew, A. (313)
Avila, C. (313)
Bagby, L. (313)
Baldin, B. (313)
Bean, A. (313)
Bernardi, G. (313)
Beuselinck, R. (313)
visa färre...
Lärosäte
Uppsala universitet (382)
Stockholms universitet (157)
Kungliga Tekniska Högskolan (138)
Karolinska Institutet (128)
Lunds universitet (63)
Göteborgs universitet (41)
visa fler...
Chalmers tekniska högskola (39)
Umeå universitet (30)
Högskolan Dalarna (13)
Luleå tekniska universitet (8)
Örebro universitet (7)
Högskolan i Skövde (7)
Linköpings universitet (4)
Sveriges Lantbruksuniversitet (3)
Jönköping University (2)
Högskolan i Halmstad (1)
Södertörns högskola (1)
Linnéuniversitetet (1)
visa färre...
Språk
Engelska (539)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (349)
Medicin och hälsovetenskap (93)
Teknik (8)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy